Steven Collis Net Worth

The estimated Net Worth of Steven H Collis is at least $107 Milion dollars as of 8 August 2023. Mr. Collis owns over 10,499 units of Amerisource Bergen stock worth over $48,318,511 and over the last 21 years he sold ABC stock worth over $47,231,640. In addition, he makes $11,309,900 as Chairman of the Board, President a Chief Executive Officer at Amerisource Bergen.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Collis ABC stock SEC Form 4 insiders trading

Steven has made over 124 trades of the Amerisource Bergen stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 10,499 units of ABC stock worth $813,987 on 8 August 2023.

The largest trade he's ever made was exercising 245,258 units of Amerisource Bergen stock on 1 May 2013 worth over $3,727,922. On average, Steven trades about 21,443 units every 40 days since 2003. As of 8 August 2023 he still owns at least 268,466 units of Amerisource Bergen stock.

You can see the complete history of Mr. Collis stock trades at the bottom of the page.

Steven Collis biography

Steven (Steve) H. Collis serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Collis is the President and Chief Executive Officer of AmerisourceBergen Corporation and has served in this position since July 2011. He has been a member of our Board since 2011 and has served as our Board's Chairman since March 2016. From November 2010 to July 2011, Mr. Collis served as President and Chief Operating Officer of AmerisourceBergen Corporation. He served as Executive Vice President and President of AmerisourceBergen Drug Corporation from September 2009 to November 2010, as Executive Vice President and President of AmerisourceBergen Specialty Group from September 2007 to September 2009 and as Senior Vice President of AmerisourceBergen Corporation and President of AmerisourceBergen Specialty Group from August 2001 to September 2007. Mr. Collis has held a variety of other positions with AmerisourceBergen Corporation and its predecessors since 1994. Mr. Collis is a member of the Board of CEOs Against Cancer (PA Chapter), and is a member of the American Red Cross Board of Governors. He previously served on the Board of International Federation of Pharmaceutical Wholesalers, Inc. until October 2018 and the board of Thoratec Corporation from 2008 to 2015.

What is the salary of Steven Collis?

As the Chairman of the Board, President a Chief Executive Officer of Amerisource Bergen, the total compensation of Steven Collis at Amerisource Bergen is $11,309,900. There are no executives at Amerisource Bergen getting paid more.

How old is Steven Collis?

Steven Collis is 58, he's been the Chairman of the Board, President a Chief Executive Officer of Amerisource Bergen since 2016. There are 13 older and 8 younger executives at Amerisource Bergen. The oldest executive at Amerisource Bergen Corp. is Jane Henney, 72, who is the Lead Independent Director.

What's Steven Collis's mailing address?

Steven's mailing address filed with the SEC is 1 WEST FIRST AVENUE, , CONSHOHOCKEN, PA, 19428.

Insiders trading at Amerisource Bergen

Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg a Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.

What does Amerisource Bergen do?

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.

Complete history of Mr. Collis stock trades at Amerisource Bergen

Amerisource Bergen executives and stock owners

Amerisource Bergen executives and other stock owners filed with the SEC include:

• Steven Collis,
  Chairman of the Board, President, Chief Executive Officer
• Steven H. Collis,
  Chairman, Pres & CEO
• Robert Mauch,
  Executive Vice President and Group President
• John Chou,
  Executive Vice President, Chief Legal Officer and Secretary
• James Cleary,
  Chief Financial Officer, Executive Vice President
• Gina Clark,
  Executive Vice President, Chief Communications & Administration Officer
• Dr. Robert P. Mauch PharmD, Ph.D.,
  Exec. VP & Group Pres
• James F. Cleary Jr.,
  Exec. VP & CFO
• John G. Chou,
  Exec. VP and Special Advisor to the Chairman & CEO
• Gina K. Clark,
  Exec. VP and Chief Communications & Admin. Officer
• Jane Henney,
  Lead Independent Director
• Henry McGee,
  Independent Director
• Michael Long,
  Independent Director
• Lon Greenberg,
  Independent Director
• Richard Gochnauer,
  Independent Director
• Kathleen Hyle,
  Independent Director
• D. Mark Durcan,
  Independent Director
• Lonie Haynes,
  Senior Vice President, Chief Diversity and Inclusion Officer
• Dennis Nally,
  Independent Director
• Ornella Barra,
  Director
• Leslie Donato,
  Executive Vice President and Chief Strategy Officer
• Silvana Battaglia,
  Chief Human Resource Officer, Executive Vice President
• Silvana Battaglia,
  Exec. VP & Chief HR Officer
• Elizabeth S. Campbell,
  Exec. VP & Chief Legal Officer
• Kathy H. Gaddes,
  Exec. VP & Chief Compliance Officer
• Bennett S. Murphy,
  Sr. VP of Investor Relations
• Lazarus Krikorian,
  Sr. VP, Chief Accounting Officer & Corp. Controller
• Douglas R Conant,
  Director
• Peyton R Howell,
  Senior Vice President
• Sun Park,
  Executive Vice President
• Kathy H. Gaddes,
  Executive Vice President
• Dale Danilewitz,
  Executive Vice President
• James Frary,
  Senior Vice President
• Tim G. Guttman,
  Acting Chief Financial Officer
• Lawrence Marsh,
  Executive Vice President
• Boots Alliance, Inc.Walgree...,
  
• Terrance P Haas,
  Senior Vice President
• Rodney H Brady,
  Director
• Kurt J Hilzinger,
  President & COO
• James R Mellor,
  Director
• Robert E Martini,
  Director
• Francis G Rodgers,
  Director
• David W Neu,
  Senior Vice President
• Charles H Cotros,
  Director
• June Barry,
  Senior Vice President
• Edward E Hagenlocker,
  Director
• Michael D Dicandilo,
  Executive VP & CFO
• Richard C Gozon,
  Director
• Jeanne B. Fisher,
  Senior Vice President
• R David Yost,
  Chief Executive Officer
• J Lawrence Wilson,
  Director
• Lazarus Krikorian,
  SVP & Chief Accounting Officer
• Elizabeth S Campbell,
  Executive Vice President
• Redonda Miller,
  Director
• Lorence H. Kim,
  Director